http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#Head
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g
http://www.nanopub.org/nschema#hasAssertion
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#assertion
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g
http://www.nanopub.org/nschema#hasProvenance
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#provenance
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g
http://www.nanopub.org/nschema#hasPublicationInfo
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#pubinfo
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.nanopub.org/nschema#Nanopublication
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#assertion
http://purl.obolibrary.org/obo/DOID_11103
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Disease
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#object
http://purl.obolibrary.org/obo/DOID_11103
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#predicate
https://w3id.org/biolink/vocab/treats
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#subject
https://identifiers.org/drugbank:DB00254
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association
http://www.w3.org/1999/02/22-rdf-syntax-ns#type
http://www.w3.org/1999/02/22-rdf-syntax-ns#Statement
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association
http://www.w3.org/2000/01/rdf-schema#label
doryx mpc is a tetracycline class drug indicated for rickettsial infections 1 1 sexually transmitted infections 1 2 respiratory tract infections 1 3 specific bacterial infections 1 4 ophthalmic infections 1 5 anthrax including inhalational anthrax post exposure 1 6 alternative treatment for selected infections when penicillin is contraindicated 1 7 adjunctive therapy in acute intestinal amebiasis and severe acne 1 8 prophylaxis of malaria 1 9 usage to reduce the development of drug resistant bacteria and maintain the effectiveness of doxycycline hyclate doryx mpc and other antibacterial drugs doryx mpc tablets should be used only to treat or prevent infections that are proven or strongly suspected to be caused by bacteria 1 1 doryx mpc is indicated for treatment of rocky mountain spotted fever typhus fever and the typhus group q fever rickettsialpox and tick fevers caused by rickettsiae doryx mpc is indicated for treatment of the following sexually transmitted infections uncomplicated urethral endocervical or rectal infections in adults caused by chlamydia trachomatis nongonococcal urethritis caused by ureaplasma urealyticum lymphogranuloma venereum caused by chlamydia trachomatis granuloma inguinale caused by klebsiella granulomatis uncomplicated gonorrhea caused by neisseria gonorrhoeae chancroid caused by haemophilus ducreyi doryx mpc is indicated for treatment of the following respiratory tract infections respiratory tract infections caused by mycoplasma pneumoniae psittacosis ornithosis caused by chlamydophila psittaci because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline culture and susceptibility testing are recommended doxycycline is indicated for treatment of infections caused by the following microorganisms when bacteriological testing indicates appropriate susceptibility to the drug haemophilus influenzae klebsiella streptococcus pneumoniae doryx mpc is indicated for treatment of the following specific bacterial infections relapsing fever due to borrelia recurrentis plague due to yersinia pestis tularemia due to francisella tularensis cholera caused by vibrio cholerae campylobacter fetus infections caused by campylobacter fetus brucellosis due to brucella bartonellosis due to bartonella bacilliformis because many strains of the following groups of microorganisms have been shown to be resistant to doxycycline culture and susceptibility testing are recommended doryx mpc is indicated for treatment of infections caused by the following gram negative microorganisms when bacteriological testing indicates appropriate susceptibility to the drug escherichia coli enterobacter aerogenes shigella species acinetobacter species urinary tract infections caused by klebsiella species doryx mpc is indicated for treatment of the following ophthalmic infections trachoma caused by chlamydia trachomatis inclusion conjunctivitis caused by chlamydia trachomatis doryx mpc is indicated for treatment of anthrax due to bacillus anthracis bacillus anthracis doryx mpc is indicated as an alternative treatment for the following selected infections when penicillin is contraindicated syphilis caused by treponema pallidum yaws caused by treponema pallidum pertenue listeriosis due to listeria monocytogenes vincent s infection caused by fusobacterium fusiforme actinomycosis caused by actinomyces israelii infections caused by clostridium in acute intestinal amebiasis doryx mpc may be a useful adjunct to amebicides in severe acne doryx mpc may be useful adjunctive therapy doryx mpc is indicated for the prophylaxis of malaria due to plasmodium falciparum see dosage and administration 2 2 patient counseling information 17 to reduce the development of drug resistant bacteria and maintain the effectiveness of doryx mpc and other antibacterial drugs doryx mpc should be used only to treat or prevent infections that are proven or strongly suspected to be caused by susceptible bacteria when culture and susceptibility information are available they should be considered in selecting or modifying antibacterial therapy in the absence of such data local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association
https://w3id.org/biolink/vocab/association_type
https://w3id.org/biolink/vocab/ChemicalToDiseaseOrPhenotypicFeatureAssociation
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association
https://w3id.org/biolink/vocab/provided_by
https://w3id.org/um/NeuroDKG
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#association
https://w3id.org/biolink/vocab/relation
https://schema.org/TreatmentIndication
https://identifiers.org/drugbank:DB00254
https://w3id.org/biolink/vocab/category
https://w3id.org/biolink/vocab/Drug
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#provenance
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#assertion
http://www.w3.org/ns/prov#wasAttributedTo
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#pubinfo
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#sig
http://purl.org/nanopub/x/hasAlgorithm
RSA
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#sig
http://purl.org/nanopub/x/hasPublicKey
MIGfMA0GCSqGSIb3DQEBAQUAA4GNADCBiQKBgQCODwZkXojpEKwk7Ldj2oPPfCstvqrcpgCaTLo235K7ht9C7E1GCkLvUuL2b4VWXJTcZx/hxgDauR8hUeYq/lS6tfTL9yFZsnfl+PWYDyz7vv6N+wJVx2LL8bO6ntCjcOzvW2t2WUeF12Sb6b3I6uOYP0N8iQKts1WasY/yEYKAHQIDAQAB
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#sig
http://purl.org/nanopub/x/hasSignature
Ct8bQcp8x4SI9tZSOoKiVoZ33sjRfT3ZbcNhhz42NPwJIAJ0WpZENX2MTeqXw/UXSEyRCT1iCUGBtNcN4MfZDsdPXsHEQ6p2mHHgL5flBNb/QZiCUY0tFRXd4EgyaR3nElWApzFunVN5btf4epXzWUFehA5d8KPvgnFm1jkbvMY=
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g#sig
http://purl.org/nanopub/x/hasSignatureTarget
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g
http://purl.org/dc/terms/created
2021-06-29T08:17:11.228+02:00
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g
http://purl.org/dc/terms/creator
https://orcid.org/0000-0002-1468-3557
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g
https://w3id.org/np/o/ntemplate/wasCreatedFromProvenanceTemplate
http://purl.org/np/RANwQa4ICWS5SOjw7gp99nBpXBasapwtZF1fIM3H2gYTM
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g
https://w3id.org/np/o/ntemplate/wasCreatedFromPubinfoTemplate
http://purl.org/np/RAA2MfqdBCzmz9yVWjKLXNbyfBNcwsMmOqcNUxkk1maIM
http://purl.org/np/RAw9wHX2aAhOacqRigufroCbGEHSXvgzWwbktF5oMu44g
https://w3id.org/np/o/ntemplate/wasCreatedFromTemplate
http://purl.org/np/RAManV5GZI01JKzW_IPcfOXoiFTcZMmsV7qTCLkdzr4Gs